Finerenone

26 trials 15 recruiting CCardiology

Filter these 26 trials by condition, phase, country and more.

Open in Search →

26 Registered trials

15 Recruiting

9 Completed trials

10 Sponsors

20 Countries

Phase III

Phase II

Phase IV

Phase III: 14 Phase II: 4 Phase IV: 7 Other: 1

Oversight events:

1 temporary halt across 1 trial

View oversight register →

Indications tested

Chronic kidney disease 11 Proteinuria 2 Albuminuria 1 Overweight 1 Obesity 1 Type 2 diabetes mellitus 1 Type 1 diabetes mellitus 1

Sponsors using this IMP

Bayer AG 8 Steno Diabetes Center Copenhagen 5 Colorado Prevention Center 3 Universitair Medisch Centrum Groningen 3 The George Institute For Global Health 2 Aarhus University Hospital 1 Novo Nordisk A/S 1 Policlinico San Donato S.p.A. 1 Region Midtjylland 1 Universitaetsklinikum Heidelberg AöR 1

All trials — page 2

26 total

A study to learn how well the treatment combination of finerenone and empagliflozin works and how safe it is compared to each treatment alon… Ended

2023-506981-30-00 Phase II 7 countries Bayer AG
A trial to learn how well finerenone works and how safe it is in adult participants with non-diabetic chronic kidney disease Ended

2023-506897-11-00 Phase III 9 countries Bayer AG

Showing 25–26 of 26 trials

← All drugs A–Z